Cargando…
Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature
Poorly differentiated cancers are a diagnostic and therapeutic challenge in oncology. New therapies are needed for patients with poorly differentiated thyroid carcinoma (PDTC) or anaplastic thyroid cancer, as these patients often present with advanced disease and effective systemic treatment options...
Autores principales: | Lote, Hazel, Bhosle, Jaishree, Thway, Khin, Newbold, Kate, O'Brien, Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107819/ https://www.ncbi.nlm.nih.gov/pubmed/25076890 http://dx.doi.org/10.1159/000364856 |
Ejemplares similares
-
High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases
por: Mori, Ryutaro, et al.
Publicado: (2014) -
Normoglycemic Diabetic Nephropathy: The Role of Insulin Resistance
por: Filippone, Edward J., et al.
Publicado: (2014) -
A Case of Bladder-Inverted Papilloma after Brachytherapy for Prostate Cancer
por: Ezaki, Taisuke, et al.
Publicado: (2014) -
Nondialytic Therapy for Elderly Patients in a Critical Care Setting
por: Ishikawa, Hideaki, et al.
Publicado: (2014) -
Acute Myelogenous Leukemia without Maturation with a Retinoic Alpha-Receptor Deletion: A Case Report
por: Trosclair, Christopher, et al.
Publicado: (2014)